Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioNTech
BNTX
|
+$1.21B |
| 2 |
Sea Limited
SE
|
+$842M |
| 3 |
Okta
OKTA
|
+$819M |
| 4 |
XYZ
Block Inc
XYZ
|
+$749M |
| 5 |
Mercado Libre
MELI
|
+$656M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$929M |
| 2 |
Union Pacific
UNP
|
+$677M |
| 3 |
Spotify
SPOT
|
+$575M |
| 4 |
RingCentral
RNG
|
+$499M |
| 5 |
Amazon
AMZN
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.98% |
| 2 | Consumer Discretionary | 23.1% |
| 3 | Communication Services | 15.59% |
| 4 | Healthcare | 8.54% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
426
DELISTED
Faro Technologies
FARO
| $12.7M | 0.01% |
193,636
+39,863
| +26% | +$2.81M |
|
427
Toast
TOST
$19.6B
| $12.5M | 0.01% |
+250,000
| New | +$13.7M |
|
428
BioLife Solutions
BLFS
$1.59B
| $12.5M | 0.01% |
294,335
-10,023
| -3% | -$483K |
|
429
Royal Gold
RGLD
$17.5B
| $12.4M | 0.01% |
129,711
+193
| +0.1% | +$21.6K |
|
430
Concrete Pumping Holdings
BBCP
$497M
| $12.1M | 0.01% |
1,414,722
+12,820
| +0.9% | +$108K |
|
|
NBP
431
NovaBridge Biosciences American Depositary Shares
NBP
$191M
| $12.1M | 0.01% |
166,485
-3,775
| -2% | -$273K |
|
|
NOVA
432
DELISTED
Sunnova Energy
NOVA
| $12M | 0.01% |
364,871
+3,590
| +1% | +$127K |
|
433
Wabtec
WAB
$50.5B
| $12M | 0.01% |
138,907
-606
| -0.4% | -$52.2K |
|
434
Denali Therapeutics
DNLI
$3.84B
| $11.5M | 0.01% |
228,422
-146,090
| -39% | -$8.23M |
|
435
Lattice Semiconductor
LSCC
$19.6B
| $11.4M | 0.01% |
176,528
-174,511
| -50% | -$10.3M |
|
436
SOPHiA GENETICS
SOPH
$574M
| $11.3M | 0.01% |
+645,417
| New | +$11.4M |
|
437
Mueller Water Products
MWA
$4.16B
| $11.3M | 0.01% |
739,880
+77,432
| +12% | +$1.19M |
|
|
PSXP
438
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $11.2M | 0.01% |
312,714
-3,060
| -1% | -$112K |
|
|
XEC
439
DELISTED
CIMAREX ENERGY CO
XEC
| $11M | 0.01% |
125,919
-51,354
| -29% | -$3.57M |
|
440
Utz Brands
UTZ
$1.25B
| $10.9M | 0.01% |
638,764
-58,257
| -8% | -$1.18M |
|
|
CVET
441
DELISTED
Covetrus, Inc. Common Stock
CVET
| $10.9M | 0.01% |
602,848
-76,764
| -11% | -$1.76M |
|
442
Kymera Therapeutics
KYMR
$8.59B
| $10.8M | 0.01% |
184,581
-2,120
| -1% | -$123K |
|
|
KRTX
443
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $10.8M | 0.01% |
+88,341
| New | +$10.2M |
|
444
Valero Energy
VLO
$88.9B
| $10.8M | 0.01% |
152,977
-38,210
| -20% | -$2.54M |
|
445
Nutrien
NTR
$32.1B
| $10.8M | 0.01% |
166,460
+1,717
| +1% | +$105K |
|
446
Bunge Global
BG
$20.5B
| $10.6M | 0.01% |
130,724
+599
| +0.5% | +$46.2K |
|
447
PMV Pharmaceuticals
PMVP
$62.4M
| $10.6M | 0.01% |
354,049
-4,103
| -1% | -$131K |
|
|
B
448
Barrick Mining
B
$64B
| $10.5M | 0.01% |
580,955
-62,804
| -10% | -$1.26M |
|
449
Halliburton
HAL
$27B
| $10.3M | 0.01% |
477,635
+1,388
| +0.3% | +$28.4K |
|
450
Integra LifeSciences
IART
$1.39B
| $10.3M | 0.01% |
149,965
-172,545
| -54% | -$12.2M |
|
Similar funds
Jennison Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Jennison Associates held 761 positions worth $155B, up 2.5% from $151B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jennison Associates's Q3 2021 filing shows 96 new, 254 increased, 288 reduced and 100 closed positions. Its largest new stake was ZoomInfo Technologies: 3,206,107 shares worth $196M. The largest sale was Match Group, an estimated $929M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2021 buy was ZoomInfo Technologies: 3,206,107 shares worth $196M.
- Jennison Associates added most to BioNTech in Q3 2021, an estimated $1.21B increase.
- Jennison Associates's biggest Q3 2021 reduction was Match Group, cutting an estimated $929M.
- Jennison Associates fully exited Zoom in Q3 2021, selling an estimated $285M.
- Jennison Associates's ten largest holdings make up 38% of its $155B portfolio in Q3 2021.
- Jennison Associates opened 96 new positions and closed 100 in Q3 2021.
- Jennison Associates's portfolio value rose 2.5% quarter-over-quarter to $155B.
Based on Jennison Associates's 13F filing for Q3 2021, filed 9 Nov 2021.